Bryan Trout
Foot & Ankle Surgery · Ankeny, IANPI 1083603278
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,468 of the $5,017 with a category attached, or 69.1%. Stryker accounts for 79.8% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2021 at $1,524 and has fallen 74.9% since, to $382 in 2025.
Across 78 payments — averaging $64.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Zimmer Biomet$255
- Johnson & Johnson$235
- Smith+Nephew$185
- Bioventus LLC$71
- Organogenesis Inc.$61
- plus $206 from 7 others
What the payments were for
- Travel & lodging$1,45529%
- Food & beverage$3,46869%
- Gifts$932%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 54 | $4,003 |
| Zimmer Biomet | 4 | $255 |
| Johnson & Johnson | 7 | $235 |
| Smith+Nephew | 2 | $185 |
| Bioventus LLC | 1 | $71 |
| Organogenesis Inc. | 2 | $61 |
| Integra Lifesciences Corporation | 2 | $61 |
| Paragon 28, Inc. | 1 | $41 |
| Misonix Inc | 1 | $33 |
| Linvatec Corporation | 1 | $22 |
| DJO, LLC | 1 | $21 |
| Pfizer | 1 | $17 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROstep$714
- PRIME SERIES$333
- AUGMENT INJECTABLE$275
- CITREFIX$213
- ORTHOLOC 2 LAPIFUSE$181
- 1788$167
- ORTHOLOC$165
- Bone Anchors with Arthroscopic Delivery System$145
- ORTHOLOC 3DI$132
- G-FORCE$126
- Nextremity General Instrument$103
How this compares
$5,017 in reported general payments places this provider in the 65th percentile of 112 foot & ankle surgery providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 74 | $1,216 |
| Etodolac | 30 | $1,023 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 108 | $966 |
| Cephalexin | 70 | $496 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $280 |
| Gabapentin | 25 | $261 |
| Terbinafine Hcl | 11 | $213 |
| Tramadol Hcl | 32 | $153 |
| Oxycodone Hcl | 16 | $116 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Ankeny
- Jesseka Kaldenberg-LeppertAnkeny$6K
- Michael LeeDes Moines$2.1M
- Phinit PhisitkulSioux City$1.4M
- Sean GrambartDes Moines$590K
- Kelsey MillonigDes Moines$330K
- Charles CibulaCedar Falls$38K
- Gregory FooteWaterloo$35K
- Nathan ShumwayCouncil Bluffs$33K
- Justin RaatzDes Moines$28K
- Tuvi MendelDavenport$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.